| ALSGD Stock | | | EUR 0.21 0.01 4.55% |
Director
Prof. Maurice Bourlion has served as Director of Spineguard S.A. since November 18, 2009 and is also Member of the Company Scientific Committee. He holds a Master of Engineering degree in Biomedical Engineering from ENSEA and also a degree in Electronics. Prof. Bourlion currently works as a lecturer at Universite Jean Monnet de Saint Etienne, France and is also Member of the New York Academy of Science. He began his career as a researcher at the Dowell Schlumberger group. Before joining the Company, he served as Executive Vice President of SpineVision and Chief Executive Officer of its NorthAmerican subsidiary in San Francisco. He worked also as Market Development Director of Medtronic and served at Lithotriteurs Extracorporels, within the Technomed International group, being Project Manager and Brand Manager. since 2009.
| Tenure | 15 years |
| Phone | 33 1 45 18 45 19 |
| Web | https://www.spineguard.com |
Spineguard Management Efficiency
The company has return on total asset
(ROA) of
(0.082) % which means that it has lost $0.082 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(0.4335) %, meaning that it generated substantial loss on money invested by shareholders. Spineguard's management efficiency ratios could be used to measure how well Spineguard manages its routine affairs as well as how well it operates its assets and liabilities.
Spineguard has accumulated 3.61
M in total debt with debt to equity ratio
(D/E) of 567.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Spineguard has a current ratio of 1.15, suggesting that it
is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Spineguard until it has trouble settling it off, either with new capital or with free cash flow. So, Spineguard's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Spineguard sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Spineguard to invest in growth at high rates of return. When we think about Spineguard's use of debt, we should always consider it together with cash and equity.
Similar Executives
The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France. SPINEGUARD operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 19 people. Spineguard (ALSGD) is traded on Euronext Paris in France and employs 21 people.
Management Performance
Spineguard Leadership Team
Elected by the shareholders, the Spineguard's board of directors comprises two types of representatives: Spineguard inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spineguard. The board's role is to monitor Spineguard's management team and ensure that shareholders' interests are well served. Spineguard's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spineguard's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pierreme, Chairman CoFounder | |
| Manuel Lanfossi, CFO, Member of the Management Board, IR Contact Officer | |
| Maurice Bourlion, CoInventor Director | |
| Patricia Lempereur, Director of Marketing & Training, International, Member of the Management Board | |
| Steve McAdoo, Vice President - Business Development, Member of the Management Board | |
| Stphane Bette, Deputy CoFounder | |
Spineguard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Spineguard a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to
measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to
predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.